Skip to main content

Table 2 Legal framework and public funding for fertility preservation for cancer patients

From: Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists

 Legal frameworkPublic healthcare system
France
Legal recommendation to offer
Bioethics Law 2004 august 6 - Article L.2141–11
“For the subsequent realization of an Assisted Reproductive Technology, any person can benefit from the collection and preservation of his gametes or germinal tissue, when a medical treatment is likely to alter fertility or when fertility is likely to be prematurely altered.”
Coverage by healthcare system for treatments inducing a loss of fertility
Social Security Code - Article D322–1
“The list of conditions involving prolonged treatment and particularly expensive treatment that may give entitlement to withdrawal of the participation of the insured persons (...): malignant tumor, malignant disease of the lymphatic or hematopoietic tissue.”
Canada
No legal recommendation to offerNo funding by healthcare system, except in the province of Quebec, where theLaw 20 Division XII.2says:
“If rendered to a fertile insured person before any oncological chemotherapy treatment or radiotherapy treatment involving a serious risk of (…) permanent infertility, (…) the fertility preservation services listed below must be considered insured services (…):
(a) the services required for ovarian stimulation or ovulation induction;
(b) the services required to retrieve eggs or ovarian tissue; (…)”
Morocco
No legal recommendation to offerNo funding by healthcare system